This podcast is supported in part by the New England Innovation Academy in Marlborough, Massachusetts,

where today's students become tomorrow's innovators by discovering their passions and purpose while preparing for what's next,

reimagining education with a future-focused curriculum, entrepreneurial mindset, and real-world application,

currently enrolling grade 6 through 12, day and boarding students.

Learn more at NEI Academy.org.

It's been more than two years since the pandemic ended, but millions of Americans are still living

with long COVID. That's a catch-all term for COVID symptoms lasting at least three months

after testing positive.

Symptoms can vary from person to person, but they range from mild to severe to physically disabling.

Recently, Health Secretary Robert F. Kennedy Jr. kicked off new efforts to address long COVID

with a roundtable discussion with doctors, researchers, and patient advocates.

In the past, the response to epidemics of this kind has been to pump a lot of money into

ivory tower science to try to solve the problem. We've already put $1.5 billion into NIH

to solve long COVID, and we've got literally nothing from it.

Ali Rogan spoke to two members of the long COVID community.

Dr. Michael Paluso, a physician and researcher at UC San Francisco, who attended that roundtable meeting.

And Megan Stone, the executive director

of the long COVID campaign.

Michael and Megan, thank you both so much for joining us. Michael, first to you, we just heard

Secretary Kennedy say that there's been nothing to show for HHS's investments so far in

long COVID research. What do you say to that? Well, I think many of us agree

that progress has really been too slow. There are a lot of patients really suffering, a lot of

...